NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

38 hedge funds and large institutions have $4.34M invested in Navidea Biopharmaceuticals Inc. in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.

Holders
38
Holders Change
-3
Holders Change %
-7.32%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
10
Reduced
9
Closed
8
Calls
$397K
Puts
$372K
Net Calls
+$25K
Net Calls Change
-$99K
Name Market Value Shares Shares
Change
Shares
Change %
LFG
26
LifePlan Financial Group
Ohio
$4K 1,440
JCM
27
Jacobi Capital Management
Pennsylvania
$3K 1,000
SIS
28
Sound Income Strategies
Florida
$2K 599
HPC
29
HM Payson & Co
Maine
$1K 300
PA
30
Parallel Advisors
California
$1K 350
Osaic Holdings
31
Osaic Holdings
Arizona
$1K 306
ASN
32
Advisory Services Network
Georgia
$1K 250 +250 New
KFS
33
Kelly Financial Services
Massachusetts
$135 50
FIA
34
FNY Investment Advisers
New York
-105,000 Closed
OFG
35
OTA Financial Group
New York
-65,600 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
-46,921 Closed
VF
37
Virtu Financial
New York
-17,586 Closed
Wolverine Trading
38
Wolverine Trading
Illinois
-15,805 Closed
CAN
39
Cetera Advisor Networks
California
-100 Closed
TI
40
tru Independence
Oregon
-100 Closed
Fidelity Investments
41
Fidelity Investments
Massachusetts
-26 Closed
SQA
42
Simon Quick Advisors
New Jersey
$0 10
IA
43
IFP Advisors
Florida
$0 50
CAPTRUST Financial Advisors
44
CAPTRUST Financial Advisors
North Carolina
$0 4
CFGS
45
Concourse Financial Group Securities
Alabama
OSAM
46
O'Shaughnessy Asset Management
Connecticut
$0 51 +51 New
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$0 160 +160 New